ARCHIVES

NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Endorse Pazdur For FDA Commissioner.

January 19, 2001

NCI Proposes Three New Grant Programs In Nutrition And Research; DRCCA Board, NCAB Approval Required

November 28, 1980

NCCS Names 7 To Board; FDA Approves Warning Labels for Hormone Therapy

January 17, 2003

DoD Ovarian Cancer Research Program seeks proposals for FY05 funding.

October 1, 2004

Nobel Laureate Gilman Prepares to Leave The Texas Cancer Agency—Can it Survive?

September 28, 2012

New CREG Cell Kinetics Study Axed By DCTBSC

March 31, 1978